Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Voies biliaires » Néoplasie

06. Novembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Voies biliaires

Cholécystite - Cholélithiase

Écriture:

Page 1 de 892


	Articles 1 - 20 / 17822

	Real-World Validation of the MAGIC-D Index in Unresectable Biliary Tract Cancer Treated With Durvalumab Plus Chemotherapy. Cancer Med Zhan T, Huang H, Zhan J, Xia F, Shao T, Liu X, Shen J, Xu X, Fan Y, Cheng Q. PMID: 42979979 [PubMed - indexed for MEDLINE]
	Single-cell and spatial transcriptomics in intrahepatic cholangiocarcinoma: spatial immune ecosystems, metabolic remodeling, and immunotherapeutic implications. Front Immunol Yan Y, Teng T, Luo X, Liu J, Wang J. PMID: 42978882 [PubMed - indexed for MEDLINE]
	Hepatic vulnerability is associated with post-hepatectomy liver failure and major morbidity after curative-intent resection of perihilar cholangiocarcinoma. BMC Surg Mantas A, Lueong SS, Mauerer S, Krumm A, Hoyer DP, Schmitz SM, Heise D, Ulmer TF, Siveke J, Neumann UP, Bednarsch J. PMID: 42977990 [PubMed - indexed for MEDLINE]
	Ivosidenib in the treatment of IDH1-mutated cholangiocarcinoma - a review of current evidence and case report demonstrating durable disease control. Klin Onkol Eid M, Eidová . PMID: 42975998 [PubMed - indexed for MEDLINE]
	Intrahepatic Cholangiocarcinoma Staging and Classification Systems: An Updated Narrative Review. J Gastrointest Cancer Marchese A, Conci S, Alaimo L, Poletto E, Campagnaro T, De Bellis M, Ruzzenente A. PMID: 42972179 [PubMed - indexed for MEDLINE]
	Safety of adjuvant brachytherapy combined with external beam radiotherapy for proximal bile duct pR1 in perihilar cholangiocarcinoma: a prospective registration study. Langenbecks Arch Surg Ahmad Al-Saffar H, Roed H, Feen Rønjom M, Weber B, Tschuor C, Nørgaard Larsen P, Kjær-Kristoffersen F, Ladekarl M, Pommergaard HC. PMID: 42970032 [PubMed - indexed for MEDLINE]
	Feature Selection and Machine Learning Strategies to Develop a Minimal Bioassay for Cholangiocarcinoma Subtype. Mayo Clin Proc Larson EL, Jessen E, Mun DG, Tomlinson JL, Abdelrahman AM, Carlson DM, Salehinejad H, Smoot RL. PMID: 42969905 [PubMed - indexed for MEDLINE]
	Same organ, divergent immunity: T-cell exhaustion versus stromal exclusion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Front Immunol Chen Y, Peng T, Nie H, Hu Y. PMID: 42964795 [PubMed - indexed for MEDLINE]
	Multikingdom and functional gut microbiota markers for cholangiocarcinoma. Genome Med Rao B, Liu S, Cui G, Jiang J, Li N, Hu J, Sun R, Li A, Zhang R, Lu H, Wen P, Xue J, Aji T, Wang H, Chen X, Zheng S, Yu Z, Ren Z. PMID: 42958435 [PubMed - indexed for MEDLINE]
	Immune-Related Biomarkers and an Exploratory Prognostic Signature in Biliary Tract and Gallbladder Cancer. J Vis Exp Zhou Z, Yang Y, Yang Z, Liu S, Gong W. PMID: 42949205 [PubMed - indexed for MEDLINE]
	Screening for Biliary Dysplasia Using Brush Cytology in PSC: Prevalence, Risk Factors and Outcomes. Liver Int Färkkilä M, Boyd S, Åberg F, Tenca A, Jokelainen K, Kautiainen H, Arola J. PMID: 42929737 [PubMed - indexed for MEDLINE]
	Mitoxyperilysis-based molecular subtyping identifies SPP1(+) macrophages and IL1B as critical mediators of tumor progression and immunotherapy resistance in intrahepatic cholangiocarcinoma. J Transl Med Wang Y, Ding K, Niu J, Li Z, Zhang X. PMID: 42919277 [PubMed - indexed for MEDLINE]
	Impact of sarcopenia on short- and long-term outcomes after resection of perihilar cholangiocarcinoma: a two-center study. BMC Cancer Wei X, Hu H, Li S, Li Q, Zhi Y, Li J, Zhu H, Tang C, Ren Y, Guo Y, Li D, Li D. PMID: 42919153 [PubMed - indexed for MEDLINE]
	Survival impact of involvement of lymph node stations 16b1, 9, and 8a during pancreatoduodenectomy for pancreatic and periampullary cancers (PANODE): prospective multicentre study. BJS Open Suurmeijer JA, Pranger BK, Seelen LWF, Ali M, van Rijssen LB, Tseng DS, Mackay TM, van Dam JL, van Santvoort HC, Groot Koerkamp B, Sarasqueta AF, van Eijck CH, Liem MSL, Kazemier G, Nieuwenhuijs VB, de Hingh IH, Klaase JM, Erdmann JI, Busch OR, Molenaar IQ, de Meijer VE, Besselink MG, Dutch Pancreatic Cancer Group. PMID: 42905970 [PubMed - indexed for MEDLINE]
	Antibody-Drug Conjugates in Biliary Tract Cancer: Current Evidence, Emerging Targets, and Future Directions. Curr Oncol Rep Liu H, Guo Y, Xue H. PMID: 42900315 [PubMed - indexed for MEDLINE]
	A prognostic model combining hilar lymph node metastasis and preoperative anemia to predict outcomes after curative resection of intrahepatic cholangiocarcinoma. BMC Cancer Deng M, He B, Lin Z, Zhang D, Qiu Y, Li D, Tang Y, Guo X, Yuan G, Qin W, Cai H, Qiu Y, Chen Z, Tang D, Wei W, Guo R. PMID: 42897511 [PubMed - indexed for MEDLINE]
	An individualized nomogram for survival prediction in intrahepatic cholangiocarcinoma: a population-based analysis. World J Surg Oncol Xie H, Wang X, Shen L, Hao F, Meng Y, Du J. PMID: 42894228 [PubMed - indexed for MEDLINE]
	A cross-sectional analysis and forward projection of China's gallbladder and biliary-tract cancer burden: Insights from the 2021 Global Burden of Disease Study. Medicine (Baltimore) Yan K, Li C, Ma J, Liu Y, Tian Y, Zhang J. PMID: 42888557 [PubMed - indexed for MEDLINE]
	Cobimetinib + Vemurafenib in Patients With BRAF V600E-Mutant Papillary Thyroid and Biliary Tract Cancers: Results From the TAPUR Study. JCO Precis Oncol Diamond-Rossi SA, Rothe M, Garrett-Mayer E, Pisick E, Bleeker J, Ganti AK, Meric-Bernstam F, Moyers JT, Nair SG, Kadakia KC, Rohatgi N, Sahai V, Vijayvergia N, Gold PJ, Sharma MR, Hinshaw DC, Gregory A, Grantham GN, Halabi S, Schilsky RL. PMID: 42886887 [PubMed - indexed for MEDLINE]
	Integrative therapy with Qinghao Biejia Decoction improves survival after resection of intrahepatic cholangiocarcinoma. J Mol Histol Chen J, Xia R, Wu M, Wang Y, Liu Y, Wang Z, Tao L. PMID: 42878941 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 17822

Page 1 de 892



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité